The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Update on lower-dose dasatinib 50 mg daily as frontline therapy in newly diagnosed chronic phase chronic myeloid leukemia (CML-CP).
 
Kiran Naqvi
Honoraria - Novartis
 
Elias Jabbour
Consulting or Advisory Role - Abbvie; Adaptive Biotechnologies; Amgen; Astellas Pharma; Bristol-Myers Squibb; Incyte; Pfizer; Takeda
Research Funding - Abbvie; Adaptive Biotechnologies; Amgen; Pfizer; Takeda
 
Jeffrey A Skinner
No Relationships to Disclose
 
Kristin N Anderson
No Relationships to Disclose
 
Musa Yilmaz
No Relationships to Disclose
 
Nitin Jain
Honoraria - Adaptive Biotechnologies; ADC Therapeutics; Novartis; Novimmune; Pfizer; Pharmacyclics; SERVIER
Consulting or Advisory Role - Adaptive Biotechnologies; ADC Therapeutics; Novartis; Novimmune; Pfizer; Pharmacyclics; SERVIER
Research Funding - Abbvie (Inst); ADC Therapeutics (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech/Roche (Inst); Incyte (Inst); Infinity Pharmaceuticals (Inst); Pfizer (Inst); Pharmacyclics (Inst); Seagen (Inst); SERVIER (Inst)
 
Alessandra Ferrajoli
Patents, Royalties, Other Intellectual Property - Acerta Pharma; Celgene; Genentech
 
Prithviraj Bose
Honoraria - Incyte
Consulting or Advisory Role - Celgene
Research Funding - Blueprint Medicines (Inst); Celgene (Inst); Celgene (Inst); CTI BioPharma Corp (Inst); Gilead Sciences (Inst); Incyte (Inst); Incyte (Inst); Incyte (Inst); NS Pharma (Inst); Promedior (Inst)
Travel, Accommodations, Expenses - Celgene; Incyte
 
Philip A. Thompson
No Relationships to Disclose
 
Yesid Alvarado
No Relationships to Disclose
 
Koichi Takahashi
Honoraria - Celgene; Kyowa Hakko Kirin; Pharmacyclics
Consulting or Advisory Role - SymBio Pharmaceuticals
Research Funding - MEI Pharma (Inst); Onconova Therapeutics (Inst)
Travel, Accommodations, Expenses - Helsinn Therapeutics; SymBio Pharmaceuticals
 
Jan Andreas Burger
Consulting or Advisory Role - Bayer; Boehringer Ingelheim; Gilead Sciences; Infinity Pharmaceuticals; Janssen; Pharmacyclics; Pharmacyclics; Pharmacyclics
Research Funding - Celgene (Inst); Gilead Sciences (Inst); Pharmacyclics (Inst); Portola Pharmaceuticals (Inst); TG Therapeutics (Inst)
 
Gautam Borthakur
No Relationships to Disclose
 
Zeev Estrov
No Relationships to Disclose
 
Naveen Pemmaraju
Honoraria - Celgene; Incyte; LFB Biotechnologies; Novartis; Stemline Therapeutics
Consulting or Advisory Role - Celgene; Incyte; LFB Biotechnologies; Novartis; Stemline Therapeutics
Research Funding - Abbvie; Affymetrix/Thermo Fisher Scientific; Cellectis; Daiichi Sankyo; Incyte; Novartis; Plexxikon; Samus Therapeutics; Stemline Therapeutics
Travel, Accommodations, Expenses - Celgene; mustangbio; Stemline Therapeutics
 
Shilpa Paul
No Relationships to Disclose
 
Sara Dellasala
No Relationships to Disclose
 
Jorge E. Cortes
Consulting or Advisory Role - Amphivena Therapeutics; Astellas Pharma; Bio-Path Holdings, Inc; BiolineRx; Bristol-Myers Squibb; Daiichi Sankyo; Jazz Pharmaceuticals; Novartis; Pfizer; Takeda
Research Funding - Arog (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Celator (Inst); Celgene (Inst); Daiichi Sankyo (Inst); Immunogen (Inst); Merus (Inst); Novartis (Inst); Pfizer (Inst); Sun Pharma (Inst); Takeda (Inst); Tolero Pharmaceuticals (Inst); Trovagene (Inst)
 
Hagop M. Kantarjian
Honoraria - Abbvie; Amgen; ARIAD; Bristol-Myers Squibb; Immunogen; Orsenix; Pfizer
Research Funding - Amgen (Inst); ARIAD (Inst); Astex Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst); Pfizer (Inst)